Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
Wednesday, March 28, 2018
Rentschler Biopharma SE announced Dr. Thomas Rösch will join the company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
read more
Wednesday, March 28, 2018
MedPharm announced a multi-million dollar investment by Ampersand Capital Partners.
read more
Wednesday, March 28, 2018
Idifarma has announced new GMP spray drying capabilities for highly potent drugs up to Category 4 OEL/OEB.
read more
Wednesday, March 28, 2018
PPD has expanded its GMP analytical laboratory in Middleton, Wisconsin.
read more
Abzena announced the completion of the facility remodeling for its new antibody-drug conjugate GMP manufacturing suite at its Bristol, Pennsylvania site.
read more
CoSara Diagnostics broke ground on the future Good Manufacturing Practices (GMP) facility in October 2017.
read more
Wednesday, March 21, 2018
WuXi Biologics has selected 4,000 liter (L) Custom Single Run (CSR) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China.
read more
Wednesday, March 21, 2018
MellingMedical was recently awarded a Federal Supply Schedule 65IB Drugs, Pharmaceuticals and Hematology Related Products.
read more
Grand River Aseptic Manufacturing (GRAM), a parenteral contract manufacturing organization, has signed purchase agreements to acquire land in Grand Rapids, Michigan.
read more
Noramco and AFC announced a strategic partnership to produce certain US DEA controlled substances for use in the treatment of addiction, abuse prevention, cannabinoids for clinical indications, and ADHD.
read more
Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK.
read more
AMPAC Fine Chemicals announced Lee Gauthier has joined AFC's executive team as Vice President of Operations responsible for manufacturing across all AFC's sites.
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more